I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Empagliflozin does not change cardiac index nor systemic va..:
Rau, Matthias
;
Thiele, Kirsten
;
Hartmann, Niels-Ulrik Korbinian
...
https://repository.publisso.de/resource/frl:6463289. , 2021
Link:
https://repository.publisso.de/resource/frl:6463289
RT Journal T1
Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study
UL https://suche.suub.uni-bremen.de/peid=base-ftzbmed:oai:frl.publisso.de:frl:6463289&Exemplar=1&LAN=DE A1 Rau, Matthias A1 Thiele, Kirsten A1 Hartmann, Niels-Ulrik Korbinian A1 Schuh, Alexander A1 Altiok, Ertunc A1 Möllmann, Julia A1 Keszei, András P A1 Böhm, Michael A1 Marx, Nikolaus A1 Lehrke, Michael YR 2021 K1 Cardiovascular Diseases/drug therapy [MeSH] K1 Benzhydryl Compounds/therapeutic use [MeSH] K1 Double-Blind Method [MeSH] K1 Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH] K1 Stroke Volume/drug effects [MeSH] K1 Aged [MeSH] K1 Diabetes Mellitus K1 Type 2/drug therapy [MeSH] K1 Diastolic function K1 Ventricular Pressure/drug effects [MeSH] K1 Original Investigation K1 Male [MeSH] K1 Glucosides/adverse effects [MeSH] K1 Hemodynamic parameters K1 SGLT2 inhibitors K1 Cardiovascular Diseases/physiopathology [MeSH] K1 Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH] K1 Type 2/diagnosis [MeSH] K1 Female [MeSH] K1 Benzhydryl Compounds/adverse effects [MeSH] K1 Recovery of Function [MeSH] K1 Heart Failure/drug therapy [MeSH] K1 Heart Failure/physiopathology [MeSH] K1 Humans [MeSH] K1 Prospective Studies [MeSH] K1 Treatment Outcome [MeSH] K1 Middle Aged [MeSH] K1 Time Factors [MeSH] K1 Diabetes K1 Glucosides/therapeutic use [MeSH] K1 Cardiovascular Diseases/diagnostic imaging [MeSH] K1 Germany [MeSH] K1 Pilot Projects [MeSH] K1 Ventricular Function K1 Left/drug effects [MeSH] K1 Vascular Resistance/drug effects [MeSH] K1 Patient Admission [MeSH] JF https://repository.publisso.de/resource/frl:6463289 LK http://dx.doi.org/https://repository.publisso.de/resource/frl:6463289 DO https://repository.publisso.de/resource/frl:6463289 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)